MoneyWorks4Me

Novartis - Quaterly Results

13 May 2026 Evaluate
The Revenue for the quarter ended  March 2026 of Rs. 905.50 millions grew by 7.95 % from Rs. 838.80 millions.A slender decline of -13.82% was recorded to Rs. 252.50  millions from Rs. 293.00 millions in the corresponding previous quarter.Operating profit for the quarter ended March 2026 decreased to 306.30 millions as compared to 345.40 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 905.50 838.80 7.95 3543.30 3562.70 -0.54 3543.30 3562.70 -0.54
Other Income 100.10 106.30 -5.83 387.70 419.60 -7.60 387.70 419.60 -7.60
PBIDT 306.30 345.40 -11.32 1328.70 1333.80 -0.38 1328.70 1333.80 -0.38
Interest 0.70 1.20 -41.67 12.60 7.70 63.64 12.60 7.70 63.64
PBDT 305.60 344.20 -11.21 1316.10 1326.10 -0.75 1316.10 1326.10 -0.75
Depreciation 4.20 5.30 -20.75 19.50 21.90 -10.96 19.50 21.90 -10.96
PBT 301.40 338.90 -11.07 1296.60 1304.20 -0.58 1296.60 1304.20 -0.58
TAX 48.90 45.90 6.54 364.80 295.20 23.58 364.80 295.20 23.58
Deferred Tax 19.60 7.50 161.33 15.30 -4.40 -447.73 15.30 -4.40 -447.73
PAT 252.50 293.00 -13.82 931.80 1009.00 -7.65 931.80 1009.00 -7.65
Equity 123.40 123.40 0.00 123.40 123.40 0.00 123.40 123.40 0.00
PBIDTM(%) 33.83 41.18 -17.85 37.50 37.44 0.16 37.50 37.44 0.16
Peers